Sara Tomei PhD

Dr. Sara Tomei completed her degree in Biology and Human Evolution at the University of Rome "Tor Vergata" (Italy) before earning her PhD in Experimental and Molecular Oncology from the University of Pisa (Italy). Before joining Sidra Medicine, she served as a Visiting Scientist at the National Institutes of Health (Bethesda, United States), where her interest was focused on understanding the genetic determinants of immune responsiveness in melanoma. She also worked as a Post-Doctoral Associate at Weill Cornell Medicine in Qatar, where she applied genomic approaches to understand the susceptibility of the Qatari and Arab populations to multifactorial diseases, including obesity and diabetes.
At Sidra Medicine (2014-present) Dr. Tomei has established a Core Facility for DNA and RNA isolation and high-throughput genomic profiling. She manages an excellent team of research specialists to serve Sidra Medicine's needs and collaborative initiatives. Since 2023, Dr. Tomei has been Acting Director of the Advanced Research Cores (ARC). In this role, she is overseeing the activities of Clinical Genomics, Omics, Genomic Data Science, Flow Cytometry, Advanced Imaging, and Zebrafish Cores as well as implementing new platforms for a large-scale biorepository.